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A 30-year-old woman with irregular menses is planning
a pregnancy. Ultrasound shows a 6-cm intramural fibroid.
She asks whether myomectomy or uterine artery emboliza-
tion (UAE) is the treatment of choice. Friends of hers have
had UAE, and she has looked at the Society of Interventional
Radiology (SIR) Web site. What would you advise? Many
women present in this fashion to general practitioners or
gynaecologists or directly to interventional radiologists.
Expert opinions differ. The SIR states that there have been
numerous reports of pregnancies after UAE. The British
Society of Interventional Radiology [1] is more cautious and
states that there is insufficient data at this time to ensure that
UAE is safe for women who may wish to become pregnant in
the future, because few studies have assessed the effect of
embolization on pregnancy-related outcomes. As radiolo-
gists, we wanted to establish the best current evidence.
The McMaster/Oxford ‘‘bottom-up’’ evidence based
practice methodology was applied to this question. Initially,
a focused clinical question or Patient Population, Interven-
tion, Comparison, Outcomes (PICO) question was designed,
as previously described by Staunton [2]: ‘‘In women with
symptomatic fibroids desiring future fertility, is uterine artery
embolization or myomectomy associated with superior
reproductive results?’’* Address for correspondence: Dearbhail O’Driscoll, MD, Radiology
Department, St James’s Hospital, James’s Street, Dublin 8, Ireland.
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Our search strategy involved a ‘‘top-down’’ trip through
the ‘‘evidence pyramid’’ hierarchy [3]. Information Systems,
synopses, syntheses, and primary studies were reviewed.
Only studies in which researchers compared reproductive
outcomes after UAE and after myomectomy were eligible
for inclusion. Expert Consensus Guidelines (level 5
evidence), review articles, abstracts, editorials, case reports,
and foreign language literature were excluded. A search of
Medline by using PubMed ‘‘Clinical Queries’’ retrieved 30
systematic reviews (SR). The abstracts of these were analysed
according to the above criteria. This left 3 relevant, accessible
SRs [4e6].
A PubMed PICO search retrieved 10 abstracts, which
were reviewed online. One randomized controlled trial was
identified [7]. Reference lists of retrieved articles were also
hand searched. This revealed a systematic literature review
and meta-analysis of 8 studies performed by Homer et al
[8]. The best current evidence is categorized as level 1b
and is derived from a randomized control trial by Mara et
al [7], who compared reproductive results after UAE and
after myomectomy. This study was reviewed by using
explicit evidence-based medicine (EBM) criteria [9], and
the methodology is satisfactory. Mara et al [7] randomized
121 women <40 years of age, with symptomatic, >4-cm
intramural fibroids, and who desired future pregnancy to
receive UAE or myomectomy. The purpose of the study
was to compare the efficacy and safety of the 2 procedures
and their impact on patient fertility.ll rights reserved.
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fibroid at least 4 cm (if multiple, then at least 1 >4 cm), age
<40 years old, serum follicle stimulating hormone (FSH)
<30 IU/L, and planned pregnancy. Exclusion criteria included
nonintramural main fibroid, dominant fibroid >12 cm on
ultrasound or uterus enlarged to a size that corresponded to
>4 months of pregnancy on bimanual pelvic examination,
previous myomectomy, UAE, or hormonal therapy of fibroids,
suspected uterine sarcoma or diffuse adenomyosis, and serious
disease contraindicating pregnancy.
Results
Fifty-eight embolizations and 63 myomectomies (42
laparoscopic, 21 open) were performed. Forty women, after
myomectomy, and 26, after UAE, have tried to conceive
(Table 1). The average length of hospitalization and post-
operative recovery were significantly longer, and the mean
serum C-reactive protein (CRP) concentration was signifi-
cantly higher in the group of women treated by surgery.
The next best current evidence is level 3a [8], a systematic
review and meta-analysis of 8 studies to investigate how
UAE might alter the risk profile for pregnancies complicated
by fibroids. In all, 227 women with completed pregnancies
after UAE for symptomatic fibroids were identified. The
main outcome measures included rates of spontaneous
abortion, preterm delivery, malpresentation, intrauterine
growth restriction, caesarean delivery, and postpartum
hemorrhage. First trimester miscarriage rates were higher in
UAE pregnancies (35.2%) compared with fibroid-containing
pregnancies matched for age and fibroid location (16.5%)
(odds ratio [OR], 2.8; confidence interval [CI], 2.0e3.8).
This result is statistically significant [10]. After the firstTable 1
Reproductive outcomes
After
UAE
After
myomectomy
Comparative statistics
(95% confidence
intervals)
Pregnancy rate 50%
(P < .05)
78%
(P < .05)
Relative risk
(not to get pregnant)
2.5 (1.20e5.18)
Absolute risk increase 0.3 (0.07e0.5)
No. needed to harm 3.3 (1.9e14)
Delivery rate 19%
(P < .05)
48%
(P < .05)
Relative risk
(not to deliver)
1.54 (1.08e2.18)
Absolute risk increase 0.28 (0.07e0.5)
No. needed to harm 3.5 (2e15.1)
Spontaneous abortion 64%
(P < .05)
23%
(P < .05)
Rate
Relative risk (to abort) 2.31 (0.93e5.72)
Absolute risk increase 0.2 (e0.02 to 0.4)a
No. needed to harm 5.1 (e56.9 to 2.4)a
aNote that, when confidence intervals cross zero, the result is not statis-
tically significant [10].trimester, there was no increased risk for preterm delivery,
malpresentation, or intrauterine growth restriction when
compared with women with untreated fibroids. After UAE,
patients were at increased risk for caesarean section (66% vs
48.5%; OR, 2.1 [95% CI, 1.4e2.9] and postpartum hemor-
rhage (13.9% vs 2.5%; OR, 6.4 [95% CI, 3.5e11.7]).Clinical ApplicabilityThere is good evidence that, for a specific subset of
patients, myomectomy achieves a higher fertility rate than
UAE (ie, <40 years old with symptomatic intramural
fibroids between 4 and 12 cm in diameter, and FSH<30 IU/L
and no previous myomectomy embolization, diffuse ade-
nomyosis, or serious disease contraindicating pregnancy).
There is also evidence that UAE likely increases the risk of
first trimester spontaneous abortion [7,8]. Further trials are
needed and at least one is in progress [11].CommentsCurrent barriers to change include the attractiveness to
patients of the minimally invasive UAE procedure, the large
financial incentives associated with all aspects of the UAE
industry, and investigator bias. However, in women who wish
to preserve maximal fertility and reduce the potential risk of
miscarriage, it remains prudent to recommend myomectomy
if technically feasible. In women who have completed their
families, or for whom myomectomy is not possible, or are
less concerned by fertility preservation, UAE can be safely
recommended. We did not anticipate this result but consider
that it has clinically significant implications for practice,
pending the completion of larger trials.
Key Points
- Although UAE is now a well-established therapeutic
procedure for patients with symptomatic uterine fibroids,
its use in women with reproductive plans remains
controversial.
- Myomectomy and embolization are comparable as far as
technical success rate, frequency of early and late
complications, and symptomatic effectiveness are
concerned.
- UAE is a less-invasive approach than myomectomy
(shorter hospital stay and recovery period, lower acute
phase markers).
- In lieu of further evidence, a cautious approach in rec-
ommending UAE to women desirous of pregnancy is
justified.
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